Skip to main content

Retinal Disorders News (Page 2)

FDA Approves Jetrea for Symptomatic Vitreomacular Adhesion in the Eyes

October 18, 2012 – On Oct. 17, the U.S. Food and Drug Administration approved Jetrea (ocriplasmin), the first drug approved to treat an eye condition called symptomatic vitreomacular adhesion (VMA)....

Ask a question

To post your own question to our community, sign in or create an account.

Further information

Related condition support groups

Eye Conditions